The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy
- 1 May 2010
- journal article
- review article
- Published by Elsevier BV in Canadian Journal of Cardiology
- Vol. 26 (5), 249-258
- https://doi.org/10.1016/s0828-282x(10)70379-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Renal and cardio-protective effects of direct renin inhibition: a systematic literature reviewJournal of Hypertension, 2009
- Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studiesBMJ, 2009
- A Simplified Approach to the Treatment of Uncomplicated HypertensionHypertension, 2009
- Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 TrialsAmerican Journal Of Medicine, 2009
- Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular HypertrophyCirculation, 2009
- Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk PatientsThe New England Journal of Medicine, 2008
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsThe New England Journal of Medicine, 2008
- Telmisartan, ramipril, or both in patients at high risk for vascular eventsThe New England Journal of Medicine, 2008
- Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)BMJ, 2007
- Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular riskBlood Pressure, 2007